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Abstract. Existing studies have demonstrated that combining genomic data and
histopathological  images  can  better  stratify  cancer  patients  with  distinct
prognosis than using single biomarker, for di erent biomarkers may provideﬀ
complementary  information.  However,  these  multi-modal  data,  most  high-
dimensional,  may  contain  redundant  fea-tures  that  will  deteriorate  the
performance of the prognosis model, and therefore it has become a challenging
problem  to  select  the  informative  features  for  survival  analysis  from  the
redundant  and  heterogeneous  fea-ture  groups.  Existing  feature  selection
methods assume that the survival information of one patient is independent to
another,  and  thus  miss  the  ordinal  relationship  among  the  survival  time  of
di erent patients. To solve this issue, we make use of the important ordinalﬀ
survival informa-tion among di erent patients and propose an ordinal sparseﬀ
canonical  correlation  analysis  (i.e.,  OSCCA)  framework  to  simultaneously
identify important image features and eigengenes for survival analysis. Specifi-
cally,  we  formulate  our  framework  basing  on  sparse  canonical  correlation
analysis model,  which aims at finding the best linear projections so that the
highest correlation between the selected image features and eigen-genes can be
achieved. In addition, we also add constrains to ensure that the ordinal survival
information of di erent patients is preserved after projection. We evaluate theﬀ
e ectiveness  of  our  method on an early-stage  renal  cell  carcinoma dataset.ﬀ
Experimental results demonstrate that the selected features correlated strongly
with survival,  by which we can achieve better patient stratification than the
comparing methods.
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1 Introduction
Cancer  is  the  most  common form of  diseases  worldwide.  It  is  reported  that  the
number of a ected people in developing country will reach 20 million annually asﬀ
early  as  2025  [1].  E ective  and  accurate  prognosis  prediction  of  human  cancer,ﬀ
especially  at  its  early  stage  has  attracted  much  attention  recently.  So  far,  many
biomarkers  have  been  shown  to  be  associated  with  the  prognosis  of  cancers,
including the histopathological images, genomic signatures, proteomics makers and
demographical information.
Fig. 1. The flowchart of the proposed method.
Early studies  on the prognosis of cancer  often focus on using single-modality
biomarker (e.g., imaging or genomic data). However, in these studies, some use-ful
complementary information across di erent modalities of data is ignored. Recently,ﬀ
some  studies  explored  to  combine  both  imaging  and  genomic  biomark-ers  for
survival analysis [2–4]. For instance, Cheng et al. [2] constructed a novel framework
that can predict the survival outcomes of patients with renal cell car-cinoma by using
a combination of quantitative image features and gene expres-sion feature. Yuan [3]
et al. integrated both image data and genomic data to improve the survival prognosis
for  breast  cancer  patients.  These  existing  studies  have  suggested  that  di erentﬀ
modalities  of  data  complement  with  each  other  and  provide  better  patient
stratification when used together.
Although integrating imaging and genomic features can better predict the clinical
outcome for  cancer  patients,  simply combing these  features  may bring  redundant
features that will deteriorate the prediction performance, and thus feature selection is
a key step for multi-modal feature fusion. In the existing studies [2,  3], the authors
usually  simply  concatenate  multi-modal  data  together  at  first,  and  then  apply
traditional  feature  selection methods (e.g., LASSO) to select  components  that  are
related to cancer prognosis. However, these feature selection methods assume that the
survival time of one patient is independent
to another, and thus missing the strong ordinal relationship among the survival time
of di erent patients, ﬀ e.g., the survival time of patient A is longer than that
of patient B. In addition, most of the studies [2, 3] directly combine morpholog-ical
and genomic data together for survival analysis, which neglects correlation
among the multi-modal data.  As a matter  of  fact,  the exploitation of  multi-modal
association has been widely accepted as a key component of the state-of-the-art multi-
modality based machine learning approaches [5].
Based on the above consideration, in this paper, we take advantage of the ordinal
survival information among di erent cancer patients, and propose an ordinal sparseﬀ
canonical  correlation  analysis  (OSCCA)  framework  that  can  select  features  from
multi-modal  data  for  survival  analysis.  Specifically,  we  formulate  our  framework
based  on  sparse  canonical  correlation  analysis  (i.e., SCCA),  which  is  a  powerful
association  method  that  can  identify  linear  projections  to  achieve  the  highest
correlation between the selected imaging and genomic components. In addition, we
add constrains to ensure that the ordinal information of di er-ent groups of patients isﬀ
preserved,  i.e., the  average  projection of  the  patients  from the  long-term survival
groups should be larger than that of short-term sur-vival groups. The experimental
results  on  a  public  available  early-stage  clear  cell  renal  cell  carcinoma (ccRCC)
dataset  demonstrate  that  the  proposed  method outperforms comparing methods in
terms of patient stratification.
Table 1. Demographics and clinical characteristics
Characteristics Summary Characteristics Summary
Patients Stage
Censored 188 Stage I 201
Non-censored 55 Stage II 42
Age (Y): 59.1 ± 12.2 Follow-up (M): 43.2 ± 25.2
2 Method
Figure  1   shows the flowchart of our framework, which includes three major steps,
i.e.,  feature extraction, ordinal  sparse canonical  correlation analysis  based fea-ture
selection (OSCCA), and prognostic prediction. Before giving the detailed descriptions
of these steps, we will firstly introduce the dataset used in this study.
Dataset:  The  Cancer  Genome  Atlas  (TCGA)  project  has  generated  multimodal
genomic and imaging data for di erent types of cancer. Renal cell carcinoma is theﬀ
most common type of cancer arising from kidney. In this study, we test our method on
an early-stage  (i.e., stage  I  and stage  II)  ccRCC dataset  [2]  derived from TCGA.
Specifically, this dataset contains pathological imaging, genomic, and clinical data for
243 early-stage renal cell carcinoma patients. Of the 243 samples, 188 patients are
censored, which means that the death events of them were not observed during the
follow-up period, and their exact survival times are longer than the recorded data. The
remaining 55 samples are non-censored patients, and their recorded survival times are
the exact time from initial diag-nosis to death. Table 1   summarizes the demographics
of all the samples.
Feature Extraction: For each image, we firstly apply the method in [6] to seg-ment
the  nucleus  in  the  whole-slide  image,  and  then  for  each  segmented  nucleus,  we
extract ten di erent features [ﬀ 2],  i.e., nuclear area (denoted as area), lengths of the
major and minor axes of cell nucleus, and the ratio of major axis length to minor axis
length  (major,  minor,  and  ratio),  mean pixel  values  of  nucleus  in  RGB channels
respectively  (rMean,  gMean,  and  bMean),  and  mean,  maximum,  and  minimum
distances (distMean, distMax, and distMin) to its neighboring nuclei.
Next, for each type of feature, a 10-bin histogram and five statistic measurements
(i.e., mean, SD, skewness, kurtosis, and entropy) are used to aggregate the cell-
level features into patient-level features, and thus a 150-dimensional imaging feature
for each patient can be obtained. Here, we use area bin1 to represent the percentage of
very small nuclei while area bin10 indicates the percentage of very large nuclei in the
patient  sample.  As to  gene  expression data,  we firstly use  co-expression network
analysis algorithms to cluster genes into co-expressed modules, and then summarize
each module as an eigengene (gene modules are shown in Supplementary Materials).
This algorithm yields 15 coexpressed gene modules. More details about the genomic
feature extraction can be found in [2].
Sparse  Canonical  Correlation  Analysis:  For  the  derived  imaging  and  eigen-gene
features,  we  implement  our  feature  selection  model  under  SCCA  frame-work.
Specifically, let XH ∈ R N ×p be the histopathological imaging data, and XG ∈ R N
×q be the extracted eigengenes data, where N is the number of the patients, and p and
q are  the  feature  number  of  imaging  data  and  eigengene  data,  respectively.  The
objective function of SCCA is:
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where the first term in Eq. (1) seeks linear transformations (i.e., ωH , ωG ) to achieve
the maximal correlation between imaging and eigengene data, the second and third
L1-norm regularized terms are used to  select  a  small  number  of  feature  that  can
maximize the association between the multi-modal data.
Ordinal  Sparse  Canonical  Correlation  Analysis:  In  the  SCCA  model,  we  only
consider the mutual dependency between imaging and genomic data, and thus ignore
the  survival  information  of  patients.  Although  the  study in  [2]  used  the  survival
information for feature selection, they assume that the survival information of one
patient is independent to another, and thus miss the strong ordinal relationship among
the survival time of di erent patients. To address this problem, we propose an ordinalﬀ
sparse canonical  correlation analysis  (OSCCA) method to simultaneously identify
important features from the multi-modal data. Specifically, we divide X = [XH , XG ]
∈ RN ×(p+q) into X C and X N C , where X C ∈ Rk×(p+q) and X N C ∈ R(N −k)×(p+q)
correspond to  the  multi-modal  features  for  censored  and  non-censored
patients,respectively, and k denotes the number of censored patients. We also define
Y = [Y C , Y N C ],
where Y C ∈ Rk and Y N C ∈ R(N −k) indicate the recorded survival time for censored
and non-censored patients, respectively. In order to reduce the chance that all patients
in one group are censored, we divide all the patients (include both censored and non-
censored patients) into four groups with equal size based on the quartiles of their
recorded  survival  time,  where  each  patient  in  group  i(i  = 1,  2,  3,  4)  has  longer
survival time than that in group j if i > j. We denote the mean imaging and eigengene
feature for censored patients in group i  as uiH and uiG , and those for non-censored
patients in group i as vHi and vGi , respectively. We show the objective function of the
OSCCA model as:
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s.t.   (vGi+1 − vGi )ωG  > 0, (vHi+1 − vHi )ωH  > 0 (3)
(uGi+1 − vGi )ωG  > 0, (uHi+1 − vHi )ωH  > 0 (4)
where the first three terms in Eq. (2) are as same as they are stated in the SCCA
model, the forth part is a regression term, where ω = [ωH , ωG ] ∈ R p+q . We use
this term to estimate the relationship between the multi-modal data and the survival
time for non-censored patients, since their survival information are accurate. We add
two  linear  inequalities  in  (3)  to  ensure  that  the  ordinal  survival  information  of
di erent  groups  of  non-censored  patients  is  preserved  after  the  projections  areﬀ
adopted on both imaging and eigengenes data. In addition, since the genuine survival
time for censored patients are longer than the recorded data, it is easy to infer that the
average projection for the censored patients in groups i + 1 should be larger than that
for non-censored patients in group i, and we also add this ordinal relationship for both
eigengene and imaging data by adding two inequality constrains shown in (4).
Optimization:  We adopt  an  alternating  strategy  to  optimize  ωH and  ωG in  the
proposed OSCCA model. Specifically, given the fixed ωH , the optimization problem
for ωG can be reformulated as:
min 1(ω )T Aω + (ω )T B + r
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where B = −(XG )T XH ωH + 2r3(XGN C )T (XHN C ωH − Y N C ), in which XGN C ∈ 
R(N −k)×p and XHN C ∈ R(N −k)×q correspond to the imaging and eigengene
data for non-censored patients, respectively. Also, A = 2r3(XGN C )T XGN C ,and
C = [vG4 − vG3;  vG3 − vG2;  vG2 − vG1;  u4G − vG3;  u3G − vG2;  u2G −
vG1]  ∈ R6×q .  For the optimization problem in (5),  we adopt the alternating
direction method of mul-
tipliers (i.e., ADMM) algorithm to solve it. To change the problem in (5) into ADMM
form, we introduce variables J ∈ Rq and non-negative vector θ ∈ R6, which is used
to transform the inequality constraints C ωG > 0 into equality
constrains C ωG − θ = 0, Eq. (5) can be reformulated as:
min 1(ω )T Aω + (ω )T B + r J
12 G G G 2 (6)ω G
s.t
. J = ωG , C ωG − θ = 0
Then, the augmented Lagrangian form of Eq. (6) can be written as:
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where  Q   and  R   are Lagrange multipliers. A general  ADMM scheme
for  Eq. (7)  repeats  the following 5  steps  until convergence: (1)ωG    ←
arg minω G L(ωG , J , θ, Q, R): It is a convex problem with respect to ωG and we can
solve it  via gradient descent method. (2)  J ← arg minJ L(ωG , J , θ, Q, R): This
optimization problem can be formulated as: minJ 
ρ
2
1 ωG − J 22 + r2 J 1 −T
(Q) J . Since the L1-norm is non-di erentiable at zero, a smooth approxima-tion hasﬀ
been estimated for L1 term by including an extremely small value. Then, by taking the
derivative regarding to  J and let it to be zero, we can obtain J = (r2D + ρ1I )−1(Q +
ρ1ωG ), where D is a diagonal matrix with the k-th element as 1/ Jk 1. Here, Jk denotes
the  k-th element in  J . (3)  θ ← arg minθ L(ωG , J , θ, Q, R): It  has a close form
solution with the  k-th element  θk = max(0, Tk ), where Tk corresponds to the k-th
element in T = C ωG + ρ12 R.
(4) Q = Q + ρ1(ωG − J ). (5) R = R + ρ2(C ωG − θ). After ωG is determined, we use similar 
method to optimize ωH .
Prognostic  Prediction:  We build  Cox  proportional  hazards  model  [2]  for  sur-vival
analysis. Specifically, we firstly divide all patients into 10 folds, with 9 folds used for
training the proposed OSCCA model  and the  remaining for  test-ing,  then  the  Cox
proportional hazards model is built on the selected features in the training set. After
that, the median risk score predicted by the cox pro-portional hazards model is used as
a threshold to split patients into low-risk and high-risk groups. Finally, we test if these
two groups has distinct survival outcome using Kaplan-Meier estimator and log-rank
test [2].
3 Experimental Results
Experimental Settings: The parameters r1, r2, r3 in the OSCCA model are tuned from
{2−4, 2−5}, {2−5, 2−6} and {2−5, 2−6}, respectively, ρ1 and ρ2 in Eq. (7) are fixed as 2−3.
All the algorithms are implemented using MATLAB 2017.
Fig. 2. Comparisons of the survival curves by applying di erent feature methods.ﬀ
Results and Discussion: We compare the prognostic power of our proposed OSCCA
method with several other methods, including LASSO [2] and RSCCA, as well as
tumor staging. Compared to the proposed OSCCA model, RSCCA method has the
same objective function (shown in Eq. (2)), but neglect to take the ordinal survival
information (shown in the inequalities in (3) and (4)) into consideration We show the
survival curves of these four methods in Fig.  2. It is observed that on one hand, the
Kaplan-Meier curves for tumor Stage I and Stage II are intertwined (log-rank test P =
0.962),  which  demonstrates  that  the  stratification  of  the  early-stage  renal  cell
carcinoma patients is a challeng-ing task, on the other hand, OSCCA could achieve
significantly  better  patient  stratification  (log-rank  test  P =  7.2e − 3)  than  the
comparing methods, which shows the advantage of using ordinal survival information
for feature selection. In addition, it is worth noting that the proposed RSCCA could
provide better prognostic prediction than the LASSO method, this is because RSCCA
considers the correlation among di erent modalities for feature selection, which isﬀ
better than the direct combination strategy.
Next, in order to investigate the association between the selected imaging feature
and eigengenes, the spearman coe cients between  ﬃ XH ωH and  XG ωG on 10-fold
testing  data  are  shown in  Fig.  3.  Obviously,  OSCCA generally  outper-forms  the
comparing methods in term of identifying high correlation between imaging data and
genomic  data,  and  the better  exploration of  the  inherent  correlation within multi-
modal data may be the reason for the better patient stratification performance of the
proposed OSCCA method.
Lastly, we compare the features selected by OSCCA with those selected by
[2] in Table 2. We find that our method can identify new types of image features (i.e.,
area bin10) that are related to large nuclei. It has been demonstrated that
the ccRCC patients with large values of nuclei size have worse prognosis [7] than
other  patients.  As  to  genomic  features,  two  novel  eigengenes  (i.e., eigengene  9,
eigengene 14) are identified. The enrichment analysis on eigengene 9 shows that it is
related to mitotic cell cycle process and genome stability, and genes in this
Table 2. Comparisons of the selected features by the method in [2] and OSCCA.
Image feature Eigengenes
LASSO [2] rMean bin8, rMean mean, Eigengene3, Eigengene13
distMean bin10, rMean mean
OSCCA rMean bin9, major kurtosis, Eigengene3, Eigengene9,
area bin10, distMin bin1, Eigengene14
bMean bin8
module are frequently observed to co-express in multiple types of  cancers  [8].  In
addition,  eigengene  14  is  enriched  with  genes  that  are  associated  with  immune
response, and it is reported that the deregulation of the immune response genes are
associated with the initiation and progression of cancers [9], and our discovery can
potentially shed light on the emerging immunotherapies. These results fur-ther shows
the  promise  of  OSCCA  to  identify  biologically  meaningful  biomarkers  for  the
prognosis of early-stage renal cancer patients.
Fig. 3. The spearman coe cients between ﬃ XH ωH  and XG ωG  on 10-fold testing data.
4 Conclusion
In this paper, we develop OSCCA which is an e ective multimodal feature selec-tionﬀ
method for patient stratification aiming at identifying subgroups of cancer patients
with distinct prognosis. The strength of our approach is its capability of utilizing the
ordinal  survival  information among di erent  patients  to  identify features  that  areﬀ
associated with patient survival time. Experimental results on an early-stage multi-
modal renal cell carcinoma dataset have demonstrated that the proposed OSCCA can
identify  new types  of  image  features  and  gene  modules  that  are  associated  with
patient survival, by which we can achieve significantly better patients stratification
than the comparing methods. Such prediction is particularly important for early stage
patients when the prediction is important yet staging information from pathologists is
not su cient to meet the needs. OSCCA is a general framework and can be used toﬃ
find  multi-modal  biomarkers  for  other  cancers  or  predict  response  of  specific
treatment, which allow for better patients management and cancer care in precision
medicine.
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